Molecular pathways involved in the synergistic interaction of the PKC beta inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells

C. Tekle, E. Giovannetti, J. Sigmond, J.R. Graff, K Smid, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)750-759
JournalBritish Journal of Cancer
Volume99
Issue number5
DOIs
Publication statusPublished - 2008

Cite this